Recent News

• 08.06.2026 - electroCore Announces Second Quarter 2026 Financial Results
• 08.03.2026 - electroCore to Participate in Upcoming Investor Conferences
• 07.16.2026 - New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation
• 06.17.2026 - electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference
• 06.09.2026 - Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery
• 06.02.2026 - electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub
• 05.13.2026 - electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia
• 05.09.2026 - electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026
• 05.06.2026 - electroCore Announces First Quarter 2026 Financial Results
• 03.19.2026 - electroCore Announces Full Year 2025 Financial Results and Organizational Changes

Recent Filings

• 08.06.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.06.2026 - 8-K Current report
• 08.06.2026 - EX-99.1 EX-99.1
• 07.20.2026 - DEF 14A Other definitive proxy statements
• 06.12.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2026 - 144 Report of proposed sale of securities
• 05.27.2026 - 144 Report of proposed sale of securities
• 05.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2026 - 4 Statement of changes in beneficial ownership of securities